UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine ... surely now be on the hit-list of potential takeover ...

Study objectives: To identify the predictors of medication adherence in patients with COPD and contrast the health beliefs, experiences, and behaviors of COPD patients self-reporting good ...

In an effort to make medical devices more accessible to all, pharmacy students at Pakistan's Karachi University have invented ...

Aerosol delivery devices are hand-held, portable drug delivery devices. They consist of suspension of solid or liquid particles in a carrier gas, which makes feasible for treatment of respiratory and ...

COPD was the underlying disease condition in 90.6% of the respondents, while asthma (5.4%), bronchiectasis ... feeling" and "I get confused about my medications" were found to be significant ...

Shares of Regeneron Pharmaceuticals, Inc. REGN have dropped 15.5% in the year so far compared with the industry’s decline of ...

Fluticasone is a prescription corticosteroid for long-term treatment of respiratory disorders, such as asthma and COPD. It is not supposed to relieve sudden breathing problems, so it won’t replace a ...

GSK plc GSK announced that the FDA has accepted its regulatory filing, seeking the approval of a new indication for Nucala (mepolizumab) in chronic obstructive pulmonary disease (COPD) treatment for ...

Hyderabad:Increasing concerns over respiratory illnesses caused by new strains of viruses and pollution have made doctors ...

According to the National Institute of Mental Health (NIMH), more than one in five adults (about 20%) in the United States has a mental health condition. Treatments for mental health conditions are ...

After hours: December 11 at 4:43:17 PM EST Loading Chart for DRUG ...